• ftr-facebook
  • ftr-instagram
  • ftr-instagram
search-icon-img

Stallion India Fluorochemicals IPO Records 70x Subscription on Day 3, NII Portion 197x Booked

Stallion India Fluorochemicals IPO Subscribed 70 Times, GMP at Rs 133.
featured-img
Stallion India Fluorochemicals IPO

The IPO of Stallion India Fluorochemicals Ltd witnessed overwhelming demand on its final bidding day (January 20), with an overall subscription of 70 times so far. The issue received 108.73 crore bids against its 1.55 crore share size.

Also Read: FPIs put back gear, withdrew 44,396 crores from stock market in 17 days

Investor Interest Breakdown

Non-Institutional Investors (NIIs): The most enthusiastic participants, oversubscribing their portion by 197 times.
Retail Investors: Subscribed their reserved portion around 55 times.
Qualified Institutional Buyers (QIBs): Subscribed 72% of their reserved portion so far, showing relatively muted interest.

Stallion India Fluorochemicals Ltd  IPO Details

Issue Structure:
Fresh Issue: 1.78 crore shares
Offer-for-Sale (OFS): 43.02 lakh shares
Price Band: Rs 85 to Rs 90 per share
Minimum Investment: 165 shares or Rs 14,850
Total Size: Rs 199.45 crore (at the upper price band)

The IPO, open for bidding between January 16 and January 20, is expected to finalize share allotments on January 21 and debut on BSE and NSE on January 23.

Grey Market Premium (GMP)

The unlisted shares of Stallion India are trading with a GMP of Rs 133, reflecting a 47.78% premium over the upper price band.

Anchor Investment

On January 15, Stallion India raised Rs 59.83 crore through its anchor book, allotting 66.48 lakh shares to six institutional investors at Rs 90 per share.

About Stallion India Fluorochemicals

The company operates in the refrigerant and industrial gases business, catering to a wide range of industries. With strong investor demand, its IPO reflects robust confidence in its growth potential.

Also Read: Effect of decreasing inflation seen, Sensex & Nifty rise; Rupee also strengthened

.

tlbr_img1 Home tlbr_img2 Shorts tlbr_img3 Video tlbr_img4 Webstories